Masso Torrence Wealth Management Inc. Purchases 796 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Masso Torrence Wealth Management Inc. grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,017 shares of the exchange traded fund’s stock after purchasing an additional 796 shares during the period. SPDR S&P Biotech ETF makes up approximately 1.3% of Masso Torrence Wealth Management Inc.’s investment portfolio, making the stock its 20th largest holding. Masso Torrence Wealth Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,433,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. FMR LLC lifted its position in SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after buying an additional 830 shares in the last quarter. Ameritas Advisory Services LLC raised its holdings in SPDR S&P Biotech ETF by 11.9% during the fourth quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after acquiring an additional 1,137 shares in the last quarter. Beaton Management Co. Inc. acquired a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $212,000. Robinson Value Management Ltd. grew its stake in SPDR S&P Biotech ETF by 1.2% in the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after purchasing an additional 155 shares in the last quarter. Finally, Granite Bay Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 4,965.8% during the 2nd quarter. Granite Bay Wealth Management LLC now owns 124,062 shares of the exchange traded fund’s stock worth $11,097,000 after purchasing an additional 121,613 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 0.2 %

NYSEARCA XBI opened at $93.34 on Wednesday. The company has a market cap of $7.11 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The stock has a 50 day moving average of $93.35 and a 200-day moving average of $96.83.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.